Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions

Eitemau Tebyg

• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
  gan: Heart Protection Study Collaborative Group
  Cyhoeddwyd: (2002)
• N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
  gan: Emberson, JR, et al.
  Cyhoeddwyd: (2007)
• Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
  gan: Collins, R, et al.
  Cyhoeddwyd: (2004)
• Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.
  gan: Mihaylova, B, et al.
  Cyhoeddwyd: (2005)
• N-BNP and vascular disease among 20,536 patients in the MRC/BHF Heart Protection Study
  gan: Emberson, J, et al.
  Cyhoeddwyd: (2005)